Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
Submitted by
admin
on October 10, 2018 - 10:10am
Source:
CP Wire
News Tags:
Celgene
ozanimod
multiple sclerosis
Headline:
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
snippet:
Ozanimod had a "beneficial effect" on cognitive processing speed
The drug also reduced relapse rates and MRI lesions compared to Avonex
Ozanimod is also in development for other immune-inflammatory indications including ulcerative colitis and Crohn's disease
Do Not Allow Advertisers to Use My Personal information
